Brief: SkinBioTherapeutics Announces Positive Interim AxisBiotix Acne study Data
Feb 27 (Reuters) - SkinBioTherapeutics PLC SBTX.L :
* INTERIM DATA FROM AXISBIOTIX ACNE FOOD SUPPLEMENT CONSUMER
PARTICIPANT STUDY WITH LEAD FORMULATION ARE VERY POSITIVE
* AXISBIOTIX ACNE FOOD SUPPLEMENT CONSUMER PARTICIPANT STUDY
FINAL
RESULTS IS ANTICIPATED TO OCCUR BEFORE END OF Q1 2024
Source text for Eikon: ID:nRSa5861Ea
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company